A new tuberculosis (TB) vaccine candidate, M72/AS01E, has entered Phase III clinical trials, with Kenyans among the 20,000 ...

UK-based big pharma GlaxoSmithKline (GSK) has released its Q2 2025 results, which highlight the varying successes of its ...

China's Jiangsu Hengrui Pharmaceuticals said on Monday it has agreed to license the global rights of its HRS-9821 drug and 11 ...

GSK will partner with Hengrui Pharma to develop up to 12 treatments for indications in respiratory, immunology and ...

The Cambridge site of an international biotechnology company will cease manufacturing, leaving 150 people without a job.

Hengrui Pharma partners with GSK to develop 12 innovative medicines, boosting globalization for Hengrui and expanding GSK's oncology and RI&I pipeline.

With the stock's last traded price at Rs 3,081, GlaxoSmithKline Pharmaceuticals has experienced a notable decline, positioning it among the top losers on the Nifty Midcap 150 index.

Laura Jensen was tapped to help Pharma Solutions reimagine their go-to-market strategies and direct-to-patient models.

Merz Aesthetics, the world’s largest dedicated medical aesthetics business, today announced two additions to its North America regional executive team: Chris Van Dyk, Vice President of U.S. Sales, and ...

Haleon partners with Indian Dental Association to inaugurate the first D20 International Symposium: Our Bureau, Mumbai Wednesday, July 30, 2025, 15:30 Hrs [IST] Haleon (erstwhile ...

Sydnie Mason laughs with her lab partner at the SNC GlaxoSmithKline Summer Immersion Experience in Biotech, a biotechnology ...